Frequently asked questions and answers to EUL assessment of IVD to detect SARS-CoV-2 or anti-SARS-CoV-2 antibodies

Overview

This page provides answers to frequently asked questions relating to EUL assessment of in vitro diagnostics (IVD) to detect SARS-CoV-2 or anti-SARS-CoV-2 antibodies. These questions and answers provide additional clarity on the procedure and instructions documents published on our website and do not intended to introduce any new requirements or to modify any existing processes in place.